Completed NA INTERVENTIONAL 2-arm NCT04224831

Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma (CSCR)

Treatment of Chronic Recalcitrant or Unresponsive Central Serous Chorioretinopathy Via Electromagnetic Stimulation And Platelet- Rich Plasma

Sponsor: Ankara Universitesi Teknokent

Conditions Central Serous Chorioretinopathy Chronic Central Serous Chorioretinopathy

Interventions Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis

Updated 5 times since 2020 Last updated: Jan 9, 2020 Started: Dec 1, 2018 Primary completion: Sep 30, 2019 Completion: Jan 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Central Serous Chorioretinopathy and Chronic Central Serous Chorioretinopathy and is currently completed. Ankara Universitesi Teknokent leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ankara Universitesi Teknokent

Data source: Ankara Universitesi Teknokent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)